Does your diet increase the risk of recurring urinary tract infections?

The influence of behavioral risk factors such as diet, body weight, and lifestyle on the prevalence of urinary infections.

Risk Adjusted Net Present Value: What is the current valuation of GSK’s GSK-3810109

The revenue for GSK-3810109 is expected to reach an annual total of $132 mn by 2038 in the US based off GlobalData’s Expiry Model. The

December 15, 2024

BMS, VantAI team up; CRISPR Therapeutics to raise $280M; Ono Pharma’s deal with Shattuck Labs

Plus, news about Areteia Therapeutics, Sudo Biosciences, Cidara Therapeutics, Xspray Pharma and Sana Biotechnology: Bristol Myers Squibb inks deal with VantAI: The pair plan to

February 14, 2024

Gilead and Assembly Biosciences to develop antiviral therapies

Gilead will acquire a 29.9% premium stake in Assembly Bio’s outstanding voting shares. Credit: Sundry Photography / Shutterstock.com. Gilead Sciences has entered a 12-year partnership

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.